Quebec confirmed on Tuesday night that a ninth thrombosis occurred in the province after the first dose of AstraZeneca was administered, which, however, ensures that the complication remains “fairly rare.”
The specified person, whose identity or age has not been disclosed in accordance with laws and regulations on the protection of personal information, “was under the supervision of a network of medical and social services and received appropriate assistance,” the Ministry of Health and Social Services (MSSS) said in a press release. release.
The man is “currently recovering at home and his health is improving,” the authorities added. This is the ninth case of thrombosis in Quebec since the start of the pandemic.
Wanting to reassure, the government adds that the health network is “mobilized to quickly take responsibility for anyone who has symptoms similar to thrombosis with thrombocytopenia (TIPIV) after receiving the vaccine.” “There are effective protocols for identifying and treating this type of complication,” we are confident in this matter.
Moreover, given the number of doses administered in Quebec, TIPIV is still viewed as “a possible complication of the AstraZeneca vaccine, but rather rare, ie about one in 50,000 vaccines given in the first dose,” says MSSS. , who also insists that the risk is even lower during the second dose, that is, in one case for about 600,000 vaccines.
However, Quebec reiterates that people who have received AstraZeneca in the first or second dose should consult a doctor if certain symptoms appear 4 to 20 days after vaccination.
Examples to be taken into account include “shortness of breath, chest pain, swelling of the legs or abdominal pain, severe headache or pain that lasted several days, blurred vision or bruising on the skin. “.
This ninth thrombosis also occurred until mid-May, when Quebec announced that the AstraZeneca vaccine would no longer be offered as a first dose, based on the recommendations of the Quebec Committee on Immunization (CIQ). The MSSS then noted that “nearly all doses available in Quebec have been consumed in recent weeks” and that “first dose administration is progressing rapidly in people aged 45 and over, the age group for which the AstraZeneca vaccine is offered”. …
In April, headlines made headlines about Francine Boyer, who died at the age of 54 from cerebral thrombosis after receiving a dose of the AstraZeneca vaccine. Prime Minister François Lego then said that he was “sad” that a woman “in good shape died due to vaccinations.” “It’s hard to accept,” he said at a press conference. “In the end, I think this is a calculated risk. But when you think about this woman, her family and loved ones, I express all my condolences to them, it is difficult. ”